Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T‐cell or T‐cell lymphoma
Authors:
- Hwei‐Fang TienHTHwei‐Fang Tien
- Jih‐Luh TangJTJih‐Luh Tang
- Ming YaoMYMing Yao
- Ih‐Jen SuISIh‐Jen Su
- Su‐Ming HsuSHSu‐Ming Hsu
- Ruey‐Long HongRHRuey‐Long Hong
Open Access
Abstract
BACKGROUND: Sinonasal natural killer (NK)/T‐cell or T‐cell lymphoma behaves quite differently from other lymphomas. The objective of this study was to investigate clinical features, treatment outcomes, and failure patterns in patients with this type of sinonasal lymphoma.METHODS: From September, 1977 to December, 2000, 77 patients with sinonasal NK/T‐cell lymphoma or T‐cell lymphoma who had received radiotherapy (R/T), chemotherapy (C/T), or both (R/T and C/T) were evaluated retrospectively.RESULTS: Fifty‐six patients (73%) had locoregional disease only, and 21 patients (27%) had systemic involvement. Forty‐four patients (57%) achieved a complete remission (CR). The 5‐year overall survival rate was 36% (median follow‐up, 89 months). Achievement of CR was the only prognostic factor for survival in multivariate analysis. Among patients with locoregional disease, the CR rate was 63%, and the 5‐year overall survival rate was 42%. Combined R/T and C/T or R/T alone resulted in better survival compared with C/T alone (5‐year survival rates, 59%, 50%, and 15%, respectively; P = 0.01). Incidences of locoregional and systemic failure were 43% and 30%, respectively. Outcome was dismal for patients with systemic disease, with a CR rate of 43% and a 5‐year survival rate of 25%. Only 2 of 21 patients had sustained remissions. The locoregional and systemic failure rates were 57% and 71%, respectively.CONCLUSIONS: Treatment outcomes were unsatisfactory for patients with locoregional and systemic sinonasal NK/T‐cell or T‐cell lymphoma. R/T could not control locoregional disease satisfactorily, and C/T was unable to eradicate systemic disease in many patients. High‐dose therapy may be worth studying in these patients. New treatments should be investigated to increase remission rates, prevent failure, and improve survival. Cancer 2004;100:366–75. © 2003 American Cancer Society.Keywords
This publication has 35 references indexed in Scilit:
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer, 2006
- Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantationBone Marrow Transplantation, 1999
- Lymphoma of the nasal cavity and paranasal sinusesCancer, 1997
- Autologous bone marrow transplantation for primary nasal T/NK cell lymphomaBone Marrow Transplantation, 1997
- Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell LymphomasAmerican Journal of Surgical Pathology, 1996
- Detection of Epstein-Barr Viral RNA in Malignant Lymphomas of the Upper Aerodigestive TractAmerican Journal of Surgical Pathology, 1994
- Epstein‐Barr virus in nasal T‐cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western ChinaThe Journal of Pathology, 1994
- Radiotherapy Compared to Chemotherapy as Initial Treatment of Angiocentric Centrofacial Lymphoma (Polymorphic Reticulosis)Acta Oncologica, 1993
- The developmental relationship between NK cells and T cellsImmunology Today, 1992
- Immunophenotypic analysis of non-hodgkin's lymphomas in Chinese. A study of 75 cases in Hong KongPathology, 1986